Safety evaluation of intake of ONO-SR/PS for healthy adults part1 - Safety evaluation of intake of ONO-SR/PS part1

EP Mediate Co., Ltd0 个研究点目标入组 10 人开始时间: 2023年11月8日最近更新: 2023年11月20日

试验速览

暂无简介。

•(1)Subjects who constantly use health food richly containing DHA, EPA, astaxanthin and shark liver oil involvement ingredient more than 1 times a week (2)Subjects who having habit of fish and selfish (including fish roe) more than 4 times a week (3)Subjects having possibilities for emerging allergy related to the study (e.g., fish, prawns, crab and spawn) (4)Subjects who having skin disease, sensitive skin on the upper arm or serious diseases for which medication was required (5)Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (6)Subjects who have diseases that require constant me dication, or who have a history of serious diseases that required medication treatment except dry eye and cavity protection (7) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (8)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (9)Subjects judged as unsuitable for the study based on the results of clinical examination or cardiopulmonary abnormality in the past (10)Subjects who are participating in other clinical research at the start of this study (11)Subjects who intend to become pregnant or lactating (12)Subjects judged as unsuitable for the study by the investigator for other reasons

发起方